See also this year's filing and all EDGAR filings for this company.
PDF Report 0001840233_2023_Xilio_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001840233, Xilio Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 124,496,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 7,255,000 |
| 3 | remainder_Assets | 7,414,000 |
| 4 | LiabilitiesCurrent | 21,119,000 |
| 5 | LiabilitiesNoncurrent | 9,234,000 |
| 6 | remainder_Liabilities | 3,165,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,948,000 |
| 9 | ResearchAndDevelopmentExpense | 59,201,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 927,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 139,165,000 |
| 1 | Liabilities | 33,518,000 |
| 2 | Expenses | 89,149,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 105,647,000 |
| 5 | NetIncome | -88,222,000 |
| 6 | ComprehensiveNetIncome | -88,222,000 |
| 7 | BaseVar | 131,379,500 |
| 8 | EconomicCapitalRatio | 1.08 |
Edgar->Model Mapping
Feature Distribution
Change over Time
